Janux Therapeutics Stock Forecast

Stock Price Forecast

According to 18 analysts polled by S&P Global, Janux Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $32.07. The average 1-year stock price forecast is 81.91% higher than the current stock price, while the lowest is $14 (-20.59%) and the highest is $60 (+240.33%).

Price Target: $32.07 (+81.91%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$14	$32.07	$28	$60
Change	-20.59%	+81.91%	+58.82%	+240.33%

Analyst Ratings

The average analyst rating for Janux Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Apr '26	May '26	Jun '26	Aug '26	Sep '26	Oct '26
Strong Buy	13	13	13	14	14	14
Buy	2	2	2	2	2	2
Hold	2	2	2	1	1	1
Sell	1	1	1	1	1	1
Strong Sell	0	0	0	0	0	0
Total	18	18	18	18	18	18

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Supawat Thongthip Truist Financial	Truist Financial	Buy Maintains $26 → $27	Buy	Maintains	$26 → $27	+53.15%	Nov 6, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $36 → $40	Buy	Reiterates	$36 → $40	+126.89%	Nov 6, 2026
Kelsey Goodwin Piper Sandler	Piper Sandler	Buy Maintains $26	Buy	Maintains	$26	+47.48%	Nov 6, 2026
Bradley Canino Guggenheim	Guggenheim	Buy Maintains $55	Buy	Maintains	$55	+211.97%	Nov 6, 2026
Alec Stranahan Bank of America Securities	Bank of America Securities	Buy Reiterates $22 → $23	Buy	Reiterates	$22 → $23	+30.46%	Nov 6, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

29.42M

from 10.00M

194.24%

from 10.00M

Revenue Next Year

8.10M

from 29.42M

-72.48%

from 29.42M

EPS This Year

-1.73

from -1.83

EPS Next Year

-2.62

from -1.73

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.64M	8.61M	8.08M	10.59M	10.00M	29.42M
Revenue Growth	-	136.79%	-6.14%	30.99%	-5.55%	194.24%
Operating Income	-32.93M	-67.09M	-72.98M	-98.85M	-157.67M	-145.06M
Net Income	-32.67M	-63.06M	-58.29M	-68.99M	-113.63M	-107.17M
EPS	-	-	-	-	-1.83	-1.73
Free Cash Flow	-	-	-	-	-83.28M	-169.00M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	77.2M
Avg	29.4M
Low	14.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	671.7%
Avg	194.2%
Low	40.0%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-0.97
Avg	-1.73
Low	-2.29

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-